Tuesday, Oct 22, 2024 · SEC filings
What the smart money revealed on Oct 22
273 insider filings came in. We hid 44 planned (10b5-1) sellers and 175 people whose filings were routine, like grants and tax withholding.
Janux Therapeutics (JANX) Director Peter Kolchinsky bought $53.7M
1.2M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
BIP Ventures Evergreen BDC CEO Mark Buffington bought $100K
3,385 shares on the open market. Not a grant or an option exercise.
Rocky Mountain Chocolate Factory (RMCF) Interim CEO Jeffrey Geygan bought $67.9K
31,109 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 6 checked quarters beat the typical stock 6 months later.
Travelers Companies (TRV) Chairman and CEO Alan Schnitzer sold $13.1M
Not marked as a planned 10b5-1 sale. Sold 18% of the shares they held directly. Still holds 230,445 shares.
Travelers Companies (TRV) EVP and Chief Tech and Ops Officer Mojgan Lefebvre sold $5.46M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day.
Plumas Bancorp (PLBC) EVP and Chief Banking Officer BJ North sold $106K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 6 more real buys
Show 24 more real sales
13F season
Holdings as of Sep 30, 2024 are due Nov 14
58 funds have filed so far. 54 filed for the quarter before.
Biggest real insider buys, Oct 16–22
Open-market buys by officers and directors, filed in the 7 days up to Oct 22.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.